TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 52 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,618 | +31.6% | 1,104 | +33.8% | 0.00% | – |
Q2 2023 | $14,908 | -47.3% | 825 | -63.4% | 0.00% | – |
Q1 2023 | $28,308 | +1204.5% | 2,252 | +1421.6% | 0.00% | – |
Q4 2022 | $2,170 | -69.0% | 148 | -62.7% | 0.00% | – |
Q3 2022 | $7,000 | +250.0% | 397 | +210.2% | 0.00% | – |
Q2 2022 | $2,000 | +100.0% | 128 | +190.9% | 0.00% | – |
Q1 2022 | $1,000 | – | 44 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |